latest news in Biotechnology

Moderna Taps Oncology Veteran Dr. David Berman to Lead Clinical Pipeline Development

Cambridge, Friday, 30 January 2026.
Immunotherapy veteran Dr. David Berman joins Moderna as Chief Development Officer, leveraging his history of leading the first T-cell receptor drug approval to accelerate the firm’s oncology and mRNA pipeline.

FDA Clears Path for Scancell's Global Phase 3 Advanced Melanoma Study

Oxford, Monday, 26 January 2026.
Authorization paves the way for a 2026 registrational trial, driven by Phase 2 results showing a 74% progression-free survival rate compared to the 50% standard.